首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   82篇
  免费   5篇
儿科学   1篇
基础医学   6篇
口腔科学   1篇
临床医学   16篇
内科学   4篇
皮肤病学   3篇
神经病学   2篇
特种医学   1篇
外科学   6篇
综合类   12篇
预防医学   8篇
药学   14篇
中国医学   13篇
  2021年   3篇
  2020年   3篇
  2019年   11篇
  2018年   7篇
  2017年   5篇
  2016年   2篇
  2015年   2篇
  2014年   7篇
  2013年   5篇
  2012年   7篇
  2011年   6篇
  2010年   10篇
  2009年   2篇
  2008年   5篇
  2007年   1篇
  2006年   2篇
  2004年   2篇
  2002年   1篇
  1999年   2篇
  1997年   1篇
  1995年   1篇
  1994年   1篇
  1992年   1篇
排序方式: 共有87条查询结果,搜索用时 31 毫秒
1.
带状疱疹后遗症神经痛(PHN)是急性带状疱疹痊愈4 ̄6周后患区留有疼痛,它的诊断并不困难,但共疼痛程度剧烈,持续时间长达3 ̄5年或更长,患者长期遭受疼前的折磨。,生活质量下降。本文报告34例(平均年龄67.8岁)胸腰段PHN患者使用硬膜外(EA)和椎旁(PVI)注药两种方法缓解疼痛的对比分析结果。EA组优良为29.4%,总有效率为52.9%;PVI组优良率为70.6%,总有效率为88.2%,两组经  相似文献   
2.
目的比较普瑞巴林和加巴喷丁治疗带状孢疹后神经痛(PHN)的临床效果和安全性。方法按自愿原则将168例患者分为A、B、C、D四组,各42例。A组给予安慰剂治疗;B组给予普瑞巴林治疗,维持治疗每日225mg;C组给予普瑞巴林治疗,每日375mg;D组给予加巴喷丁治疗。连续治疗8周后,比较治疗前、后的疼痛程度评分(VAS)变化、睡眠障碍指数(SPI)变化,并评估重点睡眠干扰评分(EMSIS)、疗效和不良反应发生率。结果各组VAS、SPI、EMSIS均明显优于A组,但不良反应发生率要高于A组,差异均有统计学意义(P〈0.05)。C组治疗后的VAS、SPI、EMSIS优于B组,差异有统计学意义(P〈0.05),但是两组在大部分不良反应发生上差异无统计学意义(P〉0.05);D组VAS评分和大部分不良反应发生率与B组比较,差异有统计学意义(P〈0.05),但是在SPI和EMSIS方面差异无统计学意义(P〉0.05)。D组在VAS评分、SPI、EMSIS和大部分不良反应发生上与C组相比,差异有统计学意义(P〈0.05)。A、B、C、D四组的治疗有效率分别为64.29%、90.48%、92.86和73.81%,治疗优良率分别为21.43%、71.43%、83.33%和54.76%。C组治疗有效率明显好于A、D组,治疗优良率明显好于A、B、D组(P〈0.05)。结论相比于安慰剂和加巴喷丁,普瑞巴林在PHN治疗中具有更好的疗效,可以显著改善患者的疼痛程度评分,减轻疼痛对睡眠的干扰。为了提升治疗有效率,剂量宜选择每日375mg,分3次口服;但是,普瑞巴林的不良反应发生率较高;在临床运用中,必须注意不良反应的观察和控制。  相似文献   
3.
目的:观察经骶尾关节奇神经节阻滞治疗老年人会阴部带状疱疹后神经痛(PHN)的效果、安全性和并发症。方法:17例老年会阴部PHN患者经骶尾关节行奇神经节阻滞,分别于治疗前、治疗后不同时间采用视觉模拟评分(VAS)法评价患者的疼痛程度、疼痛障碍指数(PDI)评定疼痛对患者日常生活的影响、匹兹堡睡眠质量指数(PSQI)评估睡眠质量。结果:患者治疗后24h、1w、4w的VAS评分、PDI评分和PSQI评分均明显低于治疗前(P<0.01),且无不良反应发生。结论:经骶尾关节行奇神经节阻滞治疗老年PHN具有穿刺路径短、疗效确切、操作简便等优点,能显著缓解会阴部PHN所导致的疼痛。  相似文献   
4.
目的:运用创新的软件面积测算法,与常规的VAS评分法比较,评定阿霉素椎旁阻滞治疗带状疱疹后遗神经痛的疗效及疾病进程的变化特点。方法:选取带状疱疹后遗神经痛患者50名,随机分为对照组与实验组,确定相应的穿刺脊椎阶段,在C形臂和神经刺激仪引导下,行椎旁穿刺。对照组每个阶段给予0.5%利多卡因2ml,甲基强地松龙10mg/1ml;实验组依次注入甲基强地松龙10mg/1ml及1%阿霉素1ml。用软件面积测算法测定治疗前与治疗后第1,3,7,14,30d疼痛面积大小,及视觉模拟(VAS)评分。结果:实验组与对照组VAS评分、疼痛面积比较除第一天外皆有显著差异(P<0.01);实验组面积数值变化呈明显下降趋势;实验组组间面积两两比较第1天与第30天比较无差异(P>0.05),余皆有显著差异(P<0.01)。结论:软件面积测算法所得面积数值变化趋势能反映阿霉素作用的有效性与顺时性效应,比较客观准确地反映治疗后疼痛减轻程度和疾病变化特点。  相似文献   
5.
目的:观察普瑞巴林治疗带状疱疹后神经痛(post-herpetic neuralgia,PHN)的有效性和安全性。方法:52例PHN患者随机分为两组,对照组(n=26)采用传统药物治疗,治疗组(n=26)采用普瑞巴林,剂量从150 mg·d-1起,根据服药后患者疼痛的缓解程度以及不良反应予以调整,疗程4周。采用数字疼痛评分量表(NRS)评估用药前及第1,2和4周的疼痛程度。结果:两组用药后NRS评分均降低,普瑞巴林组治疗后1,2和4周的NRS评分明显低于对照组。普瑞巴林组不良反应较少且轻微,主要表现为头晕和嗜睡。结论:普瑞巴林治疗带状疱疹后神经痛有效且安全。  相似文献   
6.
A great variety of therapies have been attempted for PHN, including pharmacotherapy and physical therapy. However, there has been no decisive treatment, and reports of the clinical efficacy of all available therapies have been rather controversial. Almost all studies conducted so far have looked only at short-term therapeutic efficacy, and only a few investigators have conducted long-term observations or studies on long-term outcome. We followed up the clinical efficacy of iontophoresis therapy using lidocaine and methylprednisolone in 197 PHN patients. Monitoring conducted for an average of 4 years after completion of the treatment showed that pain remained unchanged or improved compared to pain observed upon completion of the treatment in 90.4% of patients. Although 42.6% of patients were still continuing some treatment, 90.9% were found to be able to take care of themselves. Findings obtained were reviewed and discussed from various viewpoints. Our findings showed that iontophoresis therapy is not only effective at the end of the treatment, but its efficacy is maintained over a long period of time, indicating that it is clinically very useful for the treatment of PHN.  相似文献   
7.
8.

Objective

To systematically review studies examining risk factors for herpes zoster (HZ).

Methods

We performed a literature search using PubMed, EMBASE, and Web of Science for articles published from January 1, 2003, to February 1, 2017. A random-effects model was used to summarize the risk ratio (RR) or odds ratio (OR) and 95% CI.

Results

Of the 3450 studies screened, we included 84 studies in the systematic review and conducted meta-analysis in 62 studies. Women were at increased risk of HZ compared with men (pooled adjusted RR, 1.31; 95% CI, 1.27-1.34). Black individuals had almost half the risk of HZ as white individuals (pooled RR, 0.54; 95% CI, 0.47-0.63). Family history was found to be a risk factor for HZ (pooled OR, 3.59; 95% CI, 2.39-5.40). Autoimmune diseases, including rheumatoid arthritis (pooled RR, 1.67; 95% CI, 1.41-1.98) and systemic lupus erythematosus (pooled RR, 2.10; 95% CI, 1.40-3.15), were associated with an elevated risk of HZ. Other comorbidities were associated with an increased risk of HZ, with the pooled RRs ranging from 1.25 (95% CI, 1.13-1.39) for asthma to 1.30 (95% CI, 1.17-1.45) for diabetes mellitus and 1.31 (95% CI, 1.22-1.41) for chronic obstructive pulmonary disease.

Conclusion

Our review revealed that female sex, race/ethnicity, family history, and comorbidities are risk factors for HZ. Efforts are needed to increase the uptake of zoster vaccination.  相似文献   
9.

Objectives

Herpes zoster (HZ) mainly affects elderly people and immunocompromised individuals. HZ is usually characterized by a unilateral painful skin rash. Its most common complication, postherpetic neuralgia (PHN), may cause chronic debilitating pain. This study aimed to estimate the HZ incidence in individuals aged ≥50 years in Germany, the proportion of PHN and the economic burden.

Methods

From 2010 to 2014, HZ patients were recruited when consulting physicians in physician networks covering about 157,000 persons aged ≥50 years. PHN was defined as “worst pain” rated ≥3 on the zoster brief pain inventory persisting or appearing over 90 days after rash onset. Costs were calculated based on medical resource utilization and lost working time.

Results

HZ incidence was estimated as 6.7/1000 person-years, increasing with age to 9.4/1000 in ≥80 year-olds. Among 513 HZ patients enrolled, the proportion of PHN was 11.9%, rising with age to 14.3% in HZ patients ≥80 years. Estimated total cost per HZ patient was €156 from the healthcare system perspective and €311 from the societal perspective.

Conclusions

The study confirmed previous findings that HZ causes a substantial clinical and economic burden in older German adults. It also confirmed the age-related increasing risk of HZ and PHN.  相似文献   
10.
带状疱疹后遗神经痛(HPN)是临床治疗较棘手疾病之一。本文检索近年来的医学文献,归纳有关中药治疗带状疱疹后遗神经痛的临床研究报道得出结论:中药治疗HPN疗效显著,在通络止痛的基础上各有侧重,概括为以下三个方面:虚(气虚、阴血虚、阳虚)、郁(气郁、血瘀)、湿(寒湿、湿热),并予以归纳论述,供同行们参考。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号